Leadership Overview
Roche has 10 executives leading key functions including operations, strategy, finance, and organizational culture.
Driven by a commitment to personalized healthcare, Roche advances science to improve lives through innovative pharmaceutical and diagnostic solutions that address the most complex medical challenges facing patients worldwide.
Driven by a commitment to personalized healthcare, Roche advances science to improve lives through innovative pharmaceutical and diagnostic solutions that address the most complex medical challenges facing patients worldwide.
Leadership Roles at Roche
Brad Moore - President & Chief Executive Officer (Roche Diagnostics North America)
Brad Moore, the President & Chief Executive Officer (Roche Diagnostics North America) at Roche, leads the strategic direction and commercial operations for the diagnostics division across the North American market. Overseeing the deployment of advanced laboratory and tissue diagnostic solutions, the President & Chief Executive Officer (Roche Diagnostics North America) drives the adoption of personalized healthcare technologies in clinical settings. This leadership role involves managing large-scale operations and fostering partnerships with major healthcare systems to improve early disease detection. Brad Moore directs the implementation of innovative diagnostic platforms that enable precise treatment decisions for patients. By focusing on market growth and operational excellence, the President & Chief Executive Officer (Roche Diagnostics North America) ensures that the company remains at the forefront of the diagnostic industry. The President & Chief Executive Officer (Roche Diagnostics North America) collaborates with global leadership to align regional strategies with the broader mission of advancing science to improve lives through superior diagnostic capabilities.
Muhammad Noaman - Chief Financial Officer, Roche Diagnostics (Vietnam)
Muhammad Noaman, the Chief Financial Officer, Roche Diagnostics (Vietnam) at Roche, manages the financial health and fiscal strategy for diagnostic operations within the Southeast Asian market. Overseeing regional budget allocations, the Chief Financial Officer, Roche Diagnostics (Vietnam) ensures that capital investments support the expansion of early detection and laboratory diagnostic services. This leadership role involves mitigating financial risks while maximizing the impact of diagnostic product distribution across the region. Muhammad Noaman analyzes market trends to provide actionable insights that guide local business development and resource deployment. By optimizing cost structures, the Chief Financial Officer, Roche Diagnostics (Vietnam) enables the organization to provide affordable and accessible healthcare solutions to diverse patient populations. The Chief Financial Officer, Roche Diagnostics (Vietnam) works closely with local healthcare partners to integrate advanced diagnostic technologies into clinical practice, thereby improving patient outcomes and strengthening the market position of the company in this critical growth region.
Fabian Ehlen - Director, Head of Finance and Operations (Chief Financial Officer), Roche Diagnostics and Diabetes Care Australia
Fabian Ehlen, the Director, Head of Finance and Operations (Chief Financial Officer), Roche Diagnostics and Diabetes Care Australia at Roche, governs the financial and operational integrity of the diagnostics and diabetes care divisions within the Australian market. Architecting robust financial models, the Director, Head of Finance and Operations (Chief Financial Officer), Roche Diagnostics and Diabetes Care Australia ensures that resources are directed toward the advancement of diabetes management technologies and diagnostic services. This role involves overseeing the operational lifecycle of products, from regulatory compliance to market delivery. Fabian Ehlen drives fiscal discipline while fostering innovation in patient-centric care solutions. By analyzing regional healthcare data, the Director, Head of Finance and Operations (Chief Financial Officer), Roche Diagnostics and Diabetes Care Australia identifies opportunities for service expansion and operational improvement. Through strategic financial planning, the Director, Head of Finance and Operations (Chief Financial Officer), Roche Diagnostics and Diabetes Care Australia supports the delivery of high-quality care, ensuring that the company remains a leader in the Australian healthcare sector.
Diego Radiati - Chief Financial Officer, Country
Diego Radiati, the Chief Financial Officer, Country at Roche, manages the financial operations and fiscal strategy for national-level business units, ensuring compliance and profitability. Overseeing local financial reporting, the Chief Financial Officer, Country monitors revenue streams and cost structures to support the delivery of pharmaceutical and diagnostic products. This leadership role involves navigating complex regulatory environments to ensure that financial practices align with global standards. Diego Radiati provides strategic financial guidance to local management teams, enabling informed decisions regarding market expansion and resource allocation. By optimizing local financial processes, the Chief Financial Officer, Country enhances the efficiency of business operations and supports the company's mission of improving patient care. The Chief Financial Officer, Country works to maintain strong relationships with local stakeholders and healthcare providers, ensuring that financial resources are effectively utilized to meet the specific needs of the national market while contributing to the overall success of the global organization.
Peter Refler - Chief Financial Officer, Finance & Director, Roche Pharma (Vietnam)
Peter Refler, the Chief Financial Officer, Finance & Director, Roche Pharma (Vietnam) at Roche, oversees the financial governance and strategic direction of pharmaceutical operations within the Vietnamese market. Managing fiscal planning and investment strategies, the Chief Financial Officer, Finance & Director, Roche Pharma (Vietnam) ensures that resources are effectively allocated to support the distribution of oncology and immunology medicines. This leadership role involves maintaining rigorous financial controls while identifying opportunities for market growth and operational efficiency. Peter Refler analyzes local healthcare trends to guide the strategic positioning of pharmaceutical products. By fostering transparency and accountability, the Chief Financial Officer, Finance & Director, Roche Pharma (Vietnam) strengthens the financial foundation of the local business unit. The Chief Financial Officer, Finance & Director, Roche Pharma (Vietnam) works to ensure that the company provides sustainable access to innovative treatments, thereby making a meaningful difference in the fight against serious diseases within the region and supporting the global mission.
Maria del Pilar Camacho - Director, Finance & Administrative & Chief Financial Officer
Maria del Pilar Camacho, the Director, Finance & Administrative & Chief Financial Officer at Roche, governs the financial and administrative infrastructure to ensure operational stability and fiscal compliance. Overseeing the integration of financial systems and administrative processes, the Director, Finance & Administrative & Chief Financial Officer optimizes resource management to support the company's diverse healthcare divisions. This leadership role involves implementing robust internal controls and financial reporting standards that facilitate strategic decision-making. Maria del Pilar Camacho directs administrative initiatives that enhance organizational productivity and support the workforce in achieving corporate goals. By streamlining financial and administrative workflows, the Director, Finance & Administrative & Chief Financial Officer enables the company to focus on its core mission of developing innovative medicines and diagnostic solutions. The Director, Finance & Administrative & Chief Financial Officer works to ensure that all business activities are conducted with fiscal responsibility, thereby supporting the long-term growth and sustainability of the organization in the global healthcare market.
Vishal Arora - Chief Operating Officer
Vishal Arora, the Chief Operating Officer at Roche, directs the global operational framework to ensure seamless integration between pharmaceutical manufacturing and diagnostic service delivery. Overseeing complex supply chain logistics, the Chief Operating Officer optimizes resource allocation to maintain high-quality standards across international markets. This leadership role involves streamlining internal processes to accelerate the development of targeted therapies. By implementing advanced data analytics, Vishal Arora enhances operational efficiency and supports the company's mission of delivering personalized healthcare solutions. The Chief Operating Officer collaborates with regional heads to align production capacity with shifting global demand, ensuring that life-saving medicines reach patients with precision. Through rigorous oversight of operational workflows, the Chief Operating Officer drives sustainable growth and maintains the competitive edge of the organization in the rapidly evolving healthcare landscape, ultimately securing long-term value for stakeholders and patients alike.
Mia Zhao - Chief of Staff
Mia Zhao, the Chief of Staff at Roche, coordinates strategic initiatives across the executive leadership team to ensure alignment with the overarching corporate mission. Managing high-priority projects, the Chief of Staff facilitates communication between departments to accelerate decision-making processes regarding pharmaceutical research and diagnostic innovation. This role involves synthesizing complex information for the executive board to support informed strategic planning. Mia Zhao monitors the execution of long-term goals, ensuring that every division remains focused on the development of targeted therapies. By fostering cross-functional collaboration, the Chief of Staff eliminates operational silos and promotes a unified approach to global healthcare challenges. The Chief of Staff maintains a rigorous schedule of performance reviews, tracking key metrics to verify that organizational objectives remain on target. Through meticulous planning and execution, the Chief of Staff strengthens the internal infrastructure, enabling the company to respond effectively to emerging market opportunities and patient needs.
Alvin Raskina - Division For People & Culture Pharma Chief of Staff
Alvin Raskina, the Division For People & Culture Pharma Chief of Staff at Roche, shapes the organizational culture and talent strategy within the pharmaceutical division to foster a high-performance environment. Overseeing human capital initiatives, the Division For People & Culture Pharma Chief of Staff aligns workforce development with the company's commitment to scientific innovation and personalized healthcare. This leadership role involves designing programs that attract and retain top-tier researchers, scientists, and business experts. Alvin Raskina facilitates internal communication strategies that promote diversity, equity, and inclusion across global teams. By implementing performance management frameworks, the Division For People & Culture Pharma Chief of Staff ensures that every employee contributes effectively to the development of life-changing medicines. The Division For People & Culture Pharma Chief of Staff collaborates with leadership to cultivate a culture of continuous learning and agility, enabling the organization to adapt to the rapidly changing demands of the global pharmaceutical industry and maintain a focus on patient-centric outcomes.
John Pascual - Global Chief Marketing Officer & Site Manager
John Pascual, the Global Chief Marketing Officer & Site Manager at Roche, directs the worldwide marketing strategy and oversees the operational management of key corporate sites. Architecting brand positioning for pharmaceutical and diagnostic portfolios, the Global Chief Marketing Officer & Site Manager ensures that the value of personalized healthcare is communicated effectively to healthcare professionals and patients. This leadership role involves integrating marketing efforts with site-specific operational requirements to maintain high standards of service delivery. John Pascual drives the development of digital marketing initiatives that expand the reach of innovative medical solutions. By managing site operations, the Global Chief Marketing Officer & Site Manager ensures that facilities function efficiently to support research and commercial activities. The Global Chief Marketing Officer & Site Manager collaborates with cross-functional teams to align marketing campaigns with clinical evidence, ensuring that the company's market presence reflects its commitment to scientific excellence and patient-centric care on a global scale.
Explore Leadership Teams in Manufacturing
SOHO Global Health is a pioneer in natural herbal-based medicine, focusing on innovative herbal research and the development of high-quality health products. Their product range includes immune boosters, children's multivitamins, and supplements aimed at improving overall health and wellness. The company is committed to harnessing Indonesia's natural resources and indigenous plants to enhance the health of its customers. SOHO Global Health aims to create positive societal impacts through strategic partnerships and a customer-centric approach.
Company Leadership RL
HS
PB
Revance Therapeutics, Inc., a biotechnology company, engages in the development, manufacturing, and commercialization of novel botulinum toxin products for various aesthetic and therapeutic indications. The company's lead drug candidate is DaxibotulinumtoxinA for injection (RT002), which is in Phase III clinical trials to treat glabellar (frown) lines, as well as in Phase II clinical trials for the treatment of cervical dystonia and plantar fasciitis. It is also developing DaxibotulinumtoxinA topical gel (RT001) that is in preclinical development. The company was formerly known as Essentia Biosystems, Inc. and changed its name to Revance Therapeutics, Inc. in April 2005. Revance Therapeutics, Inc. was founded in 1999 and is headquartered in Newark,...
Company Leadership
SK

NC
At Curium, we have a singular focus – to develop, manufacture and supply world-class radiopharmaceutical products around the globe. We strive to innovate further in nuclear diagnostics and therapies so we can enhance the lives of people with cancer.
Every day we see the impact that our treatments offer and the potential they have to provide a world beyond cancer and other debilitating conditions. We continue to push boundaries and reach new heights in everything we do, supported by significant investment into new technologies and therapies.
Company Leadership TG
MF
JP
KE
Sandoz Group AG (SIX: SDZ) is a global healthcare company focused on developing, manufacturing, and delivering high-quality generic medicines and biosimilars. Serving patients worldwide, Sandoz provides treatments across multiple therapeutic areas, including oncology, immunology, and cardiovascular health.
Company Leadership SS
MF
BP
EM